High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-15
DOI
10.3389/fimmu.2017.01973
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy
- (2017) Rolf Billeskov et al. JOURNAL OF IMMUNOLOGY
- H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial
- (2017) Helen Mearns et al. VACCINE
- Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis
- (2017) Michelle A. Sallin et al. Cell Reports
- Early Secreted Antigenic Target of 6-kDa of Mycobacterium tuberculosis Stimulates IL-6 Production by Macrophages through Activation of STAT3
- (2017) Bock-Gie Jung et al. Scientific Reports
- Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung
- (2016) J S Woodworth et al. Mucosal Immunology
- The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions
- (2016) Sophie J. Rhodes et al. VACCINE
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
- (2016) Rein M. G. J. Houben et al. PLOS MEDICINE
- TCR Signal Strength Alters T–DC Activation and Interaction Times and Directs the Outcome of Differentiation
- (2016) Nicholas van Panhuys Frontiers in Immunology
- Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis
- (2016) Rolf Billeskov et al. PLoS One
- ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis
- (2015) Albanus O. Moguche et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+T-Cell Responses for Vaccine Control of Tuberculosis
- (2015) Mark T. Orr et al. JOURNAL OF INFECTIOUS DISEASES
- Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey
- (2015) T.J.D. Knight-Jones et al. VACCINE
- First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
- (2015) Angelique Kany Kany Luabeya et al. VACCINE
- The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
- (2015) Hennie Geldenhuys et al. VACCINE
- Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma-Homing CD4 T Cells
- (2014) S. Sakai et al. JOURNAL OF IMMUNOLOGY
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1- IL-2-Secreting Central Memory Cells
- (2013) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- Interleukin-17-dependent CXCL13 mediates mucosal vaccine–induced immunity against tuberculosis
- (2013) R Gopal et al. Mucosal Immunology
- Comparing Adjuvanted H28 and Modified Vaccinia Virus Ankara Expressing H28 in a Mouse and a Non-Human Primate Tuberculosis Model
- (2013) Rolf Billeskov et al. PLoS One
- ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre- and Post-Exposure Tuberculosis Vaccination
- (2013) Truc Hoang et al. PLoS One
- Early Secreted Antigenic Target of 6-kDa Protein of Mycobacterium tuberculosis Primes Dendritic Cells To Stimulate Th17 and Inhibit Th1 Immune Responses
- (2012) X. Wang et al. JOURNAL OF IMMUNOLOGY
- The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
- (2012) Rolf Billeskov et al. PLoS One
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Immune regulatory activities of early secreted antigenic target of 6-kD protein of Mycobacterium tuberculosis and implications for tuberculosis vaccine design
- (2011) Buka Samten et al. TUBERCULOSIS
- Suboptimal Activation of Antigen-Specific CD4+ Effector Cells Enables Persistence of M. tuberculosis In Vivo
- (2011) Tyler D. Bold et al. PLoS Pathogens
- A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo
- (2011) Alena M. Gallegos et al. PLoS Pathogens
- Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis
- (2010) Rolf Billeskov et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
- (2009) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding
- (2009) Nicolas Fazilleau et al. NATURE IMMUNOLOGY
- Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose
- (2009) Claus Aagaard et al. PLoS One
- Novel prophylactic and therapeutic vaccine against tuberculosis
- (2009) Masaji Okada et al. VACCINE
- Vaccine Adjuvants Alter TCR-Based Selection Thresholds
- (2008) Laurent Malherbe et al. IMMUNITY
- Rapid Culling of the CD4+ T Cell Repertoire in the Transition from Effector to Memory
- (2008) Matthew A. Williams et al. IMMUNITY
- Eliminating human tuberculosis in the twenty-first century
- (2007) C. Dye et al. Journal of the Royal Society Interface
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search